United Therapeutics Corp.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $526.6M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $31.9M | 6.1% |
| Stock Repurchases | $42.4M | 8.1% |
| Working Capital | $101.3M | 19.2% |
| Other | $226.1M | 42.9% |
| Net Cash Flow | $124.9M | 23.7% |